DAWN logo

DAWN Enterprise Value

Enterprise Value

$815.22 M
-$26.22 M-3.12%

7 min ago


Summary


Performance

DAWN Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherDAWNvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

DAWN Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-3.1%-2.1%-2.1%
1 m1 month-7.3%-5.0%-5.0%
3 m3 months-29.6%-21.7%-21.7%
6 m6 months-18.4%-0.3%-2.8%
ytdytd-4.9%-3.3%-3.3%
1 y1 year-28.4%-9.7%-21.9%
5 y5 years---

DAWN Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-10.6%$723 M+12.7%
3 m3-month$1.27 B-36.0%$723 M+12.7%
6 m6-month$1.27 B-36.0%$723 M+12.7%
1 y1-year$1.32 B-38.2%$723 M+12.7%
3 y3-year$1.67 B-51.2%$92 M+790.2%
5 y5-year$1.67 B-51.2%$92 M+790.2%
alltimeall time$1.67 B-51.2%$92 M+790.2%

Day One Biopharmaceuticals Enterprise Value History

DateValue
2025
$815.22 M(-4.9%)
2024
$857.57 M(-17.9%)
DateValue
2023
$1.04 B(-29.9%)
2022
$1.49 B(+96.0%)
2021
$759.81 M

FAQ

  • What is Day One Biopharmaceuticals enterprise value?
  • What is the all time high enterprise value for Day One Biopharmaceuticals?
  • What is DAWN enterprise value year-to-date change?
  • What is Day One Biopharmaceuticals enterprise value year-on-year change?

What is Day One Biopharmaceuticals enterprise value?

The current enterprise value of DAWN is $815.22 M

What is the all time high enterprise value for Day One Biopharmaceuticals?

Day One Biopharmaceuticals all-time high enterprise value is $1.67 B

What is DAWN enterprise value year-to-date change?

Day One Biopharmaceuticals enterprise value has changed by -$42.36 M (-4.94%) since the beginning of the year

What is Day One Biopharmaceuticals enterprise value year-on-year change?

Over the past year, DAWN enterprise value has changed by -$323.00 M (-28.38%)